1. Abe, T., Kobayashi, K., Nishikawa, S., Yamada, T., Hasegawa, R., Sakuratani, Y., Yamada, J., Hirose, A., Kamata, E., Yoshida, M., Sunouchi, M., Honma, M., Yamashita, T., Sakai, K., Yamazoe, Y. and Hayashi, M. (2012): Development of Hazard Evaluation Support System (HESS). Pharm stage, 12, 39-47.
2. Fasco, M.J., Hildebrandt, E.F. and Suttie, J.W. (1982): Evidence that warfarin anticoagulant action involves two distinct reductase activities. J. Biol. Chem., 257, 11210-11212.
3. Hara, K., Akiyama, Y. and Tajima, T. (1994): Sex differences in the anticoagulant effects of warfarin. Jpn. J. Pharmacol., 66, 387-392.
4. Jolly, D.W., Craig, C. and Nelson, T.E. Jr. (1977): Estrogen and prothrombin synthesis: effect of estrogen on absorption of vitamin K1. Am. J. Physiol., 232, H12-17.
5. Khoury, G. and Sheikh-Taha, M. (2014): Effect of age and sex on warfarin dosing. Clin. Pharmacol., 6, 103-106.